Clinical Trials List
2025-04-01 - 2027-12-31
Recruiting10
ICD-10C33
Malignant neoplasm of trachea
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.0
Malignant neoplasm of trachea
-
Trial Applicant
STATPLUS, INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chun-Liang Chou Division of Thoracic Medicine
- Mei-Chuan Chen Division of Thoracic Medicine
- Chi-Li Chung Division of Thoracic Medicine
- Chao-Hua Chiu Division of Thoracic Medicine
- Jia-Ruey Tsai Division of Hematology & Oncology
- Shang-Fu Hsu Division of Thoracic Medicine
- Kai-Ling Lee Division of Thoracic Medicine
- Han-Pin Kuo 無
- Cheng-I Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 柯皓文 無
- 黃振洋 無
- Ping-Chih Hsu 無
- Cheng-Ta Yang 無
- 吳教恩 無
- 枋岳甫 無
- Chih-Hsi Kuo 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- CHIN-CHOU WANG 無
- Chia-Cheng Tseng 無
- 王逸熙 無
- 李易濰 無
- 黃國棟 無
- 林理涵 無
- 張晃智 無
- 鍾聿修 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chi-Lu Chiang 無
- 廖映庭 無
- Yuh-Min Chen Division of Hematology & Oncology
- 趙恒勝 無
- YEN-HAN TSENG 無
- 蕭慈慧 無
- Hsu-ching Huang 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 郭家佑 Division of Thoracic Medicine
- 李玫萱 Division of Thoracic Medicine
- Chih-Jen Yang Division of Thoracic Medicine
- Ying-Ming Tsai Tsai Division of Thoracic Medicine
- 李岱晃 無
- 莊政皓 Division of Thoracic Medicine
- Inn-Wen Chong Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
72 participants
-
Global
300 participants